Calamos Wealth Management LLC raised its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 1.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 16,253 shares of the company’s stock after purchasing an additional 277 shares during the period. Calamos Wealth Management LLC’s holdings in Colgate-Palmolive were worth $1,478,000 at the end of the most recent reporting period.
Other hedge funds have also recently made changes to their positions in the company. Peak Financial Advisors LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $1,315,000. Gordian Advisors LLC acquired a new stake in Colgate-Palmolive in the 3rd quarter worth $602,000. Carrera Capital Advisors grew its position in Colgate-Palmolive by 23.1% during the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after acquiring an additional 7,353 shares during the last quarter. Fiduciary Alliance LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter worth $4,066,000. Finally, Vontobel Holding Ltd. raised its position in Colgate-Palmolive by 224.6% during the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock worth $82,626,000 after acquiring an additional 550,750 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several equities research analysts have weighed in on CL shares. JPMorgan Chase & Co. decreased their price target on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday. TD Cowen lowered their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Piper Sandler decreased their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Wells Fargo & Company cut their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. Finally, Stifel Nicolaus cut their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $101.16.
Colgate-Palmolive Stock Up 0.4 %
CL stock opened at $87.05 on Tuesday. The firm’s 50-day moving average is $91.35 and its two-hundred day moving average is $97.15. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 52 week low of $82.68 and a 52 week high of $109.30. The company has a market capitalization of $71.12 billion, a price-to-earnings ratio of 24.73, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the company posted $0.87 EPS. On average, analysts forecast that Colgate-Palmolive will post 3.74 earnings per share for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.30%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- T-Mobile: The Best Wireless Carrier Stock to Own Right Now?
- How Investors Can Find the Best Cheap Dividend Stocks
- Boeing: Charting a Course for Recovery and Redemption
- How to Calculate Options Profits
- Top 3 High-Momentum Companies Analysts Are Still Bullish On
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.